CompletedNot Applicable

Virtual Reality to Promote Relaxation Prior to Simulation

United States25 participantsStarted 2024-04-08

Plain-language summary

The purpose of this study is to assess the feasibility of a pre-simulation virtual reality (VR) platform designed to promote relaxation for cancer patients planned for radiation therapy (RT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to understand, read or speak English sufficient for signing of informed consent and completion of study assessments
✓. Patients scheduled for simulation for radiation treatment planning at Perelman Center for Advanced Medicine (PCAM)
✓. Adults, at least 18 years of age
✓. Performance Status (ECOG) 0-2

Exclusion criteria

✕. Prior radiotherapy
✕. History of motion sickness, car sickness, vertigo, migraines, or light sensitivity within the last 6 months
✕. History of epilepsy and seizures
✕. Current nausea, vomiting, dizziness, lightheadedness, monocular vision or hearing loss that is not treated

What they're measuring

Feasibility of a Pre-simulation VR Platform Prior to Radiation

Timeframe: 1 Day

Trial details

NCT IDNCT06318338

SponsorAbramson Cancer Center at Penn Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-12

Results submitted2025-11-25

View on ClinicalTrials.gov More Cancer trials